Clinical Trials

Every treatment that has ever made a difference in cancer was once a part of a clinical trial. The Hollings Cancer Center is committed to offering the best treatments available today while searching for even better ones for the future. As an NCI-Designated Cancer Center, Hollings offers clinical trials and therapies not available elsewhere in South Carolina, including phase I trials. Ask your doctor if a clinical trial is right for you.

Frequently Asked Questions

FAQ

Clinical trials explore promising new approaches for cancer prevention, diagnosis and treatment, often providing access to new drugs and interventions before they become widely available. Ask your doctor if a clinical trial is right for you.

Learn more about Clinical Trials

Featured Clinical Trials

Featured clinical trials

MUSC is currently enrolling prostate cancer patients to a study of a PSA-Targeted Immunotherapy product. Eligible patients must have had or are planning to have a prostatectomy within 4 months of enrollment and be considered high-risk for recurrence of disease. Please contact Dr. Michael Lilly at lillym@musc.edu or Mike Wheeler at wheelerm@musc.edu to discuss your eligibility.

Clinical Trial 102377

Patient Stories

Patient Stories

Personalized patient care is at the center of everything we do. And no one tells the story better than our patients themselves. Meet some of our patients, hear about their cancer journey and what a clinical trial has meant for them.

Patient Stories